Time Savings Gained in Retrospective Study of Glioma
MERIT provided fast, accurate reads to support the quick turnaround times of a biotech's retrospective review of an early phase Glioma study. ...
MERIT provided fast, accurate reads to support the quick turnaround times of a biotech's retrospective review of an early phase Glioma study. ...
MERIT was engaged mid-study to supply the high-quality imaging data and expertise needed to keep a Phase II glioblastoma study on track. Learn how this resulted in a significant cost savings for the Sponsor....
Anti-VEGF treatment via intravitreal injection has the potential to offer improved outcomes in the high-risk, vulnerable premature newborn population with ROP. Learn more in our case study. ...
Learn how high-quality retinal images were key to this pilot study’s success and formed the basis for testing an AI algorithm....
Learn how MERIT’s imaging expertise and proprietary software play a vital role in gene therapy clinical trials. We leverage our experience supporting 31 gene therapy clinical trials, providing valuable knowledge of specialized modalities...
MERIT’s Imaging Expertise and Proprietary Software Perform a Crucial Role in Global Phase III Wet AMD Study....
MERIT’s spirometry and MBPC expertise form the cornerstone for successful Phase III bioequivalence study for generic asthma treatment....
MERIT’s spirometry expertise and quality overreads lay the foundation for successful multi-study COPD drug development program....